Livzon Pharmaceutical Group Inc. (SHE:000513)
China flag China · Delayed Price · Currency is CNY
34.53
+0.38 (1.11%)
Apr 8, 2026, 3:04 PM CST

SHE:000513 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
9,30510,82711,32610,4119,146
Short-Term Investments
270.56----
Trading Asset Securities
1,34589.3681.79108.09182.77
Cash & Short-Term Investments
10,92110,91711,40810,5199,329
Cash Growth
0.04%-4.30%8.44%12.76%-6.52%
Accounts Receivable
3,3863,2493,5754,0393,294
Other Receivables
90.7859.2851.9131.3264.37
Receivables
3,4773,3083,6274,0713,358
Inventory
1,5611,9982,0612,0451,663
Other Current Assets
159.53197.44171.11352322.42
Total Current Assets
16,11816,42017,26616,98714,673
Property, Plant & Equipment
4,3224,5374,5664,5924,239
Long-Term Investments
1,9162,0851,6701,7381,695
Goodwill
124.91124.91124.91103.04103.04
Other Intangible Assets
468.85403.68426.28557.44260.28
Long-Term Deferred Tax Assets
427.72356.35301.92283.89252.69
Long-Term Deferred Charges
524.74396.25468.62416.74704.41
Other Long-Term Assets
84.09132.55221.17189.66444.62
Total Assets
23,98524,45625,04524,86822,372
Accounts Payable
1,3181,5841,6581,8621,817
Accrued Expenses
3,2413,1093,2953,2492,656
Short-Term Debt
2,1202,4551,8601,6222,043
Current Portion of Long-Term Debt
157.8936.21647.47--
Current Portion of Leases
15.3312.5312.210.449.28
Current Income Taxes Payable
82.43112.88181.5892.5797.45
Current Unearned Revenue
104.38124.63138226.19167.8
Other Current Liabilities
180.71191.27294.49334.42134.34
Total Current Liabilities
7,2207,6258,0877,3976,925
Long-Term Debt
749.361,4661,6131,974636.78
Long-Term Leases
17.3213.19.0311.615.27
Long-Term Unearned Revenue
242.16238.42269.37273.21258.88
Long-Term Deferred Tax Liabilities
210.28207.39209.81191.96156.89
Other Long-Term Liabilities
-0.5-908478
Total Liabilities
8,4389,55010,2789,9328,061
Common Stock
887.91911.35923.94935.55937.87
Additional Paid-In Capital
-257.851,3221,4221,629
Retained Earnings
12,73812,50611,65311,18210,461
Treasury Stock
--196.62--55.94-71.21
Comprehensive Income & Other
262.25383.57143.07391.6446.55
Total Common Equity
13,88813,86214,04213,87613,004
Minority Interest
1,6591,043724.211,0601,307
Shareholders' Equity
15,54714,90614,76714,93614,311
Total Liabilities & Equity
23,98524,45625,04524,86822,372
Total Debt
3,0603,9834,1413,6192,694
Net Cash (Debt)
7,8616,9347,2666,9016,635
Net Cash Growth
13.37%-4.57%5.29%4.01%-17.58%
Net Cash Per Share
8.807.537.817.377.09
Filing Date Shares Outstanding
887.91908.91923.94932.23929.97
Total Common Shares Outstanding
887.91908.91923.94932.23929.97
Working Capital
8,8988,7959,1799,5917,748
Book Value Per Share
15.6415.2515.2014.8813.98
Tangible Book Value
13,29513,33413,49113,21612,640
Tangible Book Value Per Share
14.9714.6714.6014.1813.59
Buildings
--3,745-3,123
Machinery
8,9868,7294,5517,5773,764
Construction In Progress
234.18257.37289.31602.44554.58
Source: S&P Global Market Intelligence. Standard template. Financial Sources.